nsclc Search Results


94
AMS Biotechnology non small cell lung cancer nsclc adenocarcinoma
Non Small Cell Lung Cancer Nsclc Adenocarcinoma, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nsclc/Human+Lung+cancer%2C+non-small+cell+(NSCLC)+adenocarcinoma+FFPE+block/10__1158_slash_1535___7163__mct___24___0588-98-51-82
Average 94 stars, based on 1 article reviews
non small cell lung cancer nsclc adenocarcinoma - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
AMS Biotechnology small cell lung cancer sclc
Small Cell Lung Cancer Sclc, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nsclc/Human+Lung+Cancer%2C+non-small+cell+(NSCLC)+FFPE+Scrolls/10__1158_slash_1535___7163__mct___24___0588-98-69-82
Average 94 stars, based on 1 article reviews
small cell lung cancer sclc - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
Schmid GmbH nsclc
Nsclc, supplied by Schmid GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nsclc/nsclc/pmc05904969-104-14-32
Average 90 stars, based on 1 article reviews
nsclc - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare nsclc patients treated with icb
Nsclc Patients Treated With Icb, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nsclc/nsclc+patients+treated+with+icb/pmc07514475-322-9-11
Average 90 stars, based on 1 article reviews
nsclc patients treated with icb - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
EPO GmbH nsclc pdx models
Nsclc Pdx Models, supplied by EPO GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nsclc/nsclc+pdx+models/10__1158_slash_1535___7163__mct___16___0474-250-2-8
Average 90 stars, based on 1 article reviews
nsclc pdx models - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Broad Institute Inc lung cancer cell lines
Lung Cancer Cell Lines, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nsclc/nsclc+cell+lines/pmc06188056__oncotarget___09___33995___s001-1-5-19
Average 90 stars, based on 1 article reviews
lung cancer cell lines - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Creative Dynamics human nsclc cell line hcc-15
Human Nsclc Cell Line Hcc 15, supplied by Creative Dynamics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nsclc/human+nsclc+cell+line+hcc+15/pmc06670022-52-11-19
Average 90 stars, based on 1 article reviews
human nsclc cell line hcc-15 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Hamamatsu nsclc tumor specimens
Nsclc Tumor Specimens, supplied by Hamamatsu, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nsclc/nsclc+tumor+specimens/pm37999107-40-4-25
Average 90 stars, based on 1 article reviews
nsclc tumor specimens - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
BioMimetic Therapeutics genetically engineered nsclc cell lines
Genetically Engineered Nsclc Cell Lines, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nsclc/genetically+engineered+nsclc+cell+lines/pmc10802790-299-3-12
Average 90 stars, based on 1 article reviews
genetically engineered nsclc cell lines - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Cureline Inc flash-frozen melanoma cancer biopsy
Flash Frozen Melanoma Cancer Biopsy, supplied by Cureline Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nsclc/snap+frozen+nsclc+and+crc+tumor+samples/pmc11155269-457-10-22
Average 90 stars, based on 1 article reviews
flash-frozen melanoma cancer biopsy - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Caris Life Sciences nsclc
Nsclc, supplied by Caris Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nsclc/nsclc+tumors/10__1158_slash_2159___8290__cd___23___1217-83-38-10
Average 90 stars, based on 1 article reviews
nsclc - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Human Protein Atlas immunochemistry results of tpx2 in nsclc
<t>TPX2</t> was selected as the key candidate gene in regulating the malignant progression of <t>NSCLC.</t> ( A ) Heatmap analysis of DEGs revealed a substantial difference between circulating and nonmetastatic NSCLC tumor cells. ( B ) Volcano plot for the DEGs between circulating and nonmetastatic NSCLC tumor cells, where the red and green plots indicating the upregulated and downregulated genes, respectively. ( C ) PPI network analysis of DEGs revealed NSCLC-related PPI hubs, and topological PPI network indicated TPX2 as a key node gene. DEGs – differentially expressed genes; CTCs – circulating tumor cells; Ctrl – nonmetastatic NSCLC tumor cells; PPI – protein–protein interaction.
Immunochemistry Results Of Tpx2 In Nsclc, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nsclc/immunochemistry+results+of+tpx2+in+nsclc/pmc07427348-415-6-15
Average 90 stars, based on 1 article reviews
immunochemistry results of tpx2 in nsclc - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


TPX2 was selected as the key candidate gene in regulating the malignant progression of NSCLC. ( A ) Heatmap analysis of DEGs revealed a substantial difference between circulating and nonmetastatic NSCLC tumor cells. ( B ) Volcano plot for the DEGs between circulating and nonmetastatic NSCLC tumor cells, where the red and green plots indicating the upregulated and downregulated genes, respectively. ( C ) PPI network analysis of DEGs revealed NSCLC-related PPI hubs, and topological PPI network indicated TPX2 as a key node gene. DEGs – differentially expressed genes; CTCs – circulating tumor cells; Ctrl – nonmetastatic NSCLC tumor cells; PPI – protein–protein interaction.

Journal: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research

Article Title: TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer

doi: 10.12659/MSM.925147

Figure Lengend Snippet: TPX2 was selected as the key candidate gene in regulating the malignant progression of NSCLC. ( A ) Heatmap analysis of DEGs revealed a substantial difference between circulating and nonmetastatic NSCLC tumor cells. ( B ) Volcano plot for the DEGs between circulating and nonmetastatic NSCLC tumor cells, where the red and green plots indicating the upregulated and downregulated genes, respectively. ( C ) PPI network analysis of DEGs revealed NSCLC-related PPI hubs, and topological PPI network indicated TPX2 as a key node gene. DEGs – differentially expressed genes; CTCs – circulating tumor cells; Ctrl – nonmetastatic NSCLC tumor cells; PPI – protein–protein interaction.

Article Snippet: The immunochemistry results of TPX2 in NSCLC were obtained from the open website of The Human Protein Atlas ( https://www.proteinatlas.org/ ).

Techniques:

Correlation of TPX2 with NSCLC tumor characteristics in clinical samples. ( A ) TPX2 staining was weakly positive and strongly positive in nonmetastatic and metastatic lung cancer tissues, separately. ( B ) TPX2 expression was significantly upregulated in the metastatic NSCLC samples compared with the nonmetastatic NSCLC samples. ( C ) TPX2 expression was significantly increased with the NSCLC tumor size. ( D ) TPX2 expression was significantly increased with the NSCLC clinical stage. ( E ) Overall survival analysis of TPX2 on patients with NSCLC (mean±SD; ** P <0.01).

Journal: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research

Article Title: TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer

doi: 10.12659/MSM.925147

Figure Lengend Snippet: Correlation of TPX2 with NSCLC tumor characteristics in clinical samples. ( A ) TPX2 staining was weakly positive and strongly positive in nonmetastatic and metastatic lung cancer tissues, separately. ( B ) TPX2 expression was significantly upregulated in the metastatic NSCLC samples compared with the nonmetastatic NSCLC samples. ( C ) TPX2 expression was significantly increased with the NSCLC tumor size. ( D ) TPX2 expression was significantly increased with the NSCLC clinical stage. ( E ) Overall survival analysis of TPX2 on patients with NSCLC (mean±SD; ** P <0.01).

Article Snippet: The immunochemistry results of TPX2 in NSCLC were obtained from the open website of The Human Protein Atlas ( https://www.proteinatlas.org/ ).

Techniques: Staining, Expressing

TPX2 affected NSCLC migration, invasion, and cell replasticity. ( A ) Relative TPX2 expression analysis in 5 NSCLC cell lines; the ratio of densitometry value to the corresponding GAPDH value was used to reveal the relative protein expression. ( B ) The upregulation of TPX2 promoted the migration of the A549 cells, whereas its downregulation inhibited the migration of the H1650 cells. ( C ) The upregulation of TPX2 promoted the invasion of the A549 cells, whereas its downregulation inhibited the invasion of the H1650 cells. ( D ) Morphological observations of different treated A549 cells in pseudopod and cell rounding (mean±SD; n=3 in triplicate; ** P <0.01).

Journal: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research

Article Title: TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer

doi: 10.12659/MSM.925147

Figure Lengend Snippet: TPX2 affected NSCLC migration, invasion, and cell replasticity. ( A ) Relative TPX2 expression analysis in 5 NSCLC cell lines; the ratio of densitometry value to the corresponding GAPDH value was used to reveal the relative protein expression. ( B ) The upregulation of TPX2 promoted the migration of the A549 cells, whereas its downregulation inhibited the migration of the H1650 cells. ( C ) The upregulation of TPX2 promoted the invasion of the A549 cells, whereas its downregulation inhibited the invasion of the H1650 cells. ( D ) Morphological observations of different treated A549 cells in pseudopod and cell rounding (mean±SD; n=3 in triplicate; ** P <0.01).

Article Snippet: The immunochemistry results of TPX2 in NSCLC were obtained from the open website of The Human Protein Atlas ( https://www.proteinatlas.org/ ).

Techniques: Migration, Expressing

Correlations of TPX2 with EMT and MMPs in NSCLC cells. ( A ) The expression of epithelial marker proteins was consistent with TPX2 content, whereas the expression of mesenchymal marker proteins was opposite the expression of TPX2. ( B ) Luciferase reporter assay results suggested that TPX2 promoted the transcriptional activities of MMP2 and MMP9. ( C ) The enzyme activities of MMP2 and MMP9 were detected by using the activity detecting kit. Expression of both MMP2 and MMP9 activities was significantly higher in the TPX2 overexpression group of A549 cells, whereas in the knockdown group of H1650 cells, the MMP2 and MMP9 activities were significantly decreased when TPX2 was knocked down (mean±SD; n=3 in triplicate; ** P <0.01).

Journal: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research

Article Title: TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer

doi: 10.12659/MSM.925147

Figure Lengend Snippet: Correlations of TPX2 with EMT and MMPs in NSCLC cells. ( A ) The expression of epithelial marker proteins was consistent with TPX2 content, whereas the expression of mesenchymal marker proteins was opposite the expression of TPX2. ( B ) Luciferase reporter assay results suggested that TPX2 promoted the transcriptional activities of MMP2 and MMP9. ( C ) The enzyme activities of MMP2 and MMP9 were detected by using the activity detecting kit. Expression of both MMP2 and MMP9 activities was significantly higher in the TPX2 overexpression group of A549 cells, whereas in the knockdown group of H1650 cells, the MMP2 and MMP9 activities were significantly decreased when TPX2 was knocked down (mean±SD; n=3 in triplicate; ** P <0.01).

Article Snippet: The immunochemistry results of TPX2 in NSCLC were obtained from the open website of The Human Protein Atlas ( https://www.proteinatlas.org/ ).

Techniques: Expressing, Marker, Luciferase, Reporter Assay, Activity Assay, Over Expression, Knockdown

Proposed regulatory mechanism of TPX2 in the metastasis and malignant progression of NSCLC.

Journal: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research

Article Title: TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer

doi: 10.12659/MSM.925147

Figure Lengend Snippet: Proposed regulatory mechanism of TPX2 in the metastasis and malignant progression of NSCLC.

Article Snippet: The immunochemistry results of TPX2 in NSCLC were obtained from the open website of The Human Protein Atlas ( https://www.proteinatlas.org/ ).

Techniques: